Mark Smith
Nucleus Directors
Head of Medicinal Chemistry
Dr. Mark Smith is Director of the Medicinal Chemistry within the Sarafan ChEM-H Institute Nucleus and Co-Director of the Small Molecule Portfolio in Stanford's Innovative Medicines Accelerator (IMA). In addition, Dr. Smith is Director of the Sarafan ChEM-H Undergraduate Entrepreneurship Program. Prior to Stanford, Dr. Smith was a Senior Scientist at Roche Pharmaceuticals where his research focused on the discovery of small molecule inhibitors for HIV reverse transcriptase, HCV polymerase and NS5A, influenza endonuclease and cap polymerase. Dr. Smith also led Roche's nucleoside chemistry efforts in the virology therapeutic area.
Education
Postdoc, University of Illinois at Chicago, Chemistry
Ph.D., University of Manchester Institute of Science and Technology (UMIST), Chemistry
BSc, University of Greenwich, Chemistry with Business Management